Search
Regorafenib now FDA-approved to treat hepatocellular ...
Approved use of the drug has been expanded to include treatment of patients with hepatocellular carcinoma who have been treated with sorafenib.
Duodenoscopes recalled | ACP Gastroenterology Monthly
The recall of ED-530XT duodenoscopes by Fujifilm includes replacement of the ED-530XT forceps elevator mechanism (including the O-ring seal), ...
New HCV drug combo approved | ACP Gastroenterology ...
The fixed-dose tablet combines the previously approved drugs sofosbuvir and velpatasvir with a new drug, voxilaprevir.
Drug for chronic idiopathic constipation approved | ACP ...
The oral medication is taken once per day and works in the upper GI tract to stimulate secretion of intestinal fluid, supporting regular bowel function.
IBS-D drug should not be prescribed to patients without ...
The FDA suggests that clinicians should consider alternatives to eluxadoline in this population.
New drug approved for carcinoid syndrome diarrhea | ACP ...
The drug reduces the frequency of diarrhea by inhibiting the production of serotonin by carcinoid tumors.
Generic form of mesalamine approved | ACP ...
The drug is indicated to induce remission in adults with active, mild to moderate ulcerative colitis and to maintain remission of ulcerative colitis.